• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟药物青蒿素的构效关系。6. 使用比较分子场分析(CoMFA)和基于历史定量结构-活性关系(HQSAR)方法建立体外预测效价模型。

Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies.

作者信息

Avery Mitchell A, Alvim-Gaston Maria, Rodrigues Carlos R, Barreiro Eliezer J, Cohen Fred E, Sabnis Yogesh A, Woolfrey John R

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Thad Cochran National Center for Natural Products Research, University of Mississippi, University, Mississippi 38677, USA.

出版信息

J Med Chem. 2002 Jan 17;45(2):292-303. doi: 10.1021/jm0100234.

DOI:10.1021/jm0100234
PMID:11784134
Abstract

Artemisinin (1) is a unique sesquiterpene peroxide occurring as a constituent of Artemisia annua L. Because of the effectiveness of Artemisinin in the treatment of drug-resistant Plasmodium falciparum and its rapid clearance of cerebral malaria, development of clinically useful semisynthetic drugs for severe and complicated malaria (artemether, artesunate) was prompt. However, recent reports of fatal neurotoxicity in animals with dihydroartemisinin derivatives such as artemether have spawned a renewed effort to develop nontoxic analogues of artemisinin. In our effort to develop more potent, less neurotoxic agents for the oral treatment of drug-resistant malaria, we utilized comparative molecular field analysis (CoMFA) and hologram QSAR (HQSAR), beginning with a series of 211 artemisinin analogues with known in vitro antimalarial activity. CoMFA models were based on two conformational hypotheses: (a) that the X-ray structure of artemisinin represents the bioactive shape of the molecule or (b) that the hemin-docked conformation is the bioactive form of the drug. In addition, we examined the effect of inclusion or exclusion of racemates in the partial least squares (pls) analysis. Databases derived from the original 211 were split into chiral (n = 157), achiral (n = 34), and mixed databases (n = 191) after leaving out a test set of 20 compounds. HQSAR and CoMFA models were compared in terms of their potential to generate robust QSAR models. The r(2) and q(2) (cross-validated r(2)) were used to assess the statistical quality of our models. Another statistical parameter, the ratio of the standard error to the activity range (s/AR), was also generated. CoMFA and HQSAR models were developed having statistically excellent properties, which also possessed good predictive ability for test set compounds. The best model was obtained when racemates were excluded from QSAR analysis. Thus, CoMFA of the n = 157 database gave excellent predictions with outstanding statistical properties. HQSAR did an outstanding job in statistical analysis and also handled predictions well.

摘要

青蒿素(1)是一种独特的倍半萜过氧化物,是青蒿的一种成分。由于青蒿素在治疗耐多药恶性疟原虫方面的有效性及其对脑型疟疾的快速清除作用,临床上用于治疗严重和复杂疟疾的半合成药物(蒿甲醚、青蒿琥酯)迅速得到开发。然而,最近有报道称,蒿甲醚等双氢青蒿素衍生物在动物中具有致命的神经毒性,这促使人们重新努力开发青蒿素的无毒类似物。为了开发更有效、神经毒性更小的药物用于口服治疗耐多药疟疾,我们利用比较分子场分析(CoMFA)和全息定量构效关系(HQSAR),从一系列211种具有已知体外抗疟活性的青蒿素类似物开始。CoMFA模型基于两种构象假设:(a)青蒿素的X射线结构代表分子的生物活性形状,或(b)血红素对接构象是药物的生物活性形式。此外,我们还研究了在偏最小二乘法(pls)分析中包含或排除外消旋体的影响。在剔除20种化合物的测试集后,将源自原始211种化合物的数据库分为手性(n = 157)、非手性(n = 34)和混合数据库(n = 191)。从生成稳健的定量构效关系模型的潜力方面对HQSAR和CoMFA模型进行了比较。r(2)和q(2)(交叉验证的r(2))用于评估我们模型的统计质量。还生成了另一个统计参数,即标准误差与活性范围的比值(s/AR)。开发的CoMFA和HQSAR模型具有统计学上优异的性质,对测试集化合物也具有良好的预测能力。当在外消旋体定量构效关系分析中排除外消旋体时,获得了最佳模型。因此,对n = 157的数据库进行CoMFA分析给出了具有出色统计性质的优异预测。HQSAR在统计分析方面表现出色,在预测方面也处理得很好。

相似文献

1
Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies.抗疟药物青蒿素的构效关系。6. 使用比较分子场分析(CoMFA)和基于历史定量结构-活性关系(HQSAR)方法建立体外预测效价模型。
J Med Chem. 2002 Jan 17;45(2):292-303. doi: 10.1021/jm0100234.
2
Molecular docking and 3-D-QSAR studies on the possible antimalarial mechanism of artemisinin analogues.青蒿素类似物抗疟作用机制的分子对接及三维定量构效关系研究
Bioorg Med Chem. 2002 Sep;10(9):2883-91. doi: 10.1016/s0968-0896(02)00161-x.
3
Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria.抗疟药物青蒿素的构效关系。8. 基于青蒿素开发抗利什曼病和疟疾药物的设计、合成及比较分子力场分析研究
J Med Chem. 2003 Sep 25;46(20):4244-58. doi: 10.1021/jm030181q.
4
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.青蒿素类抗疟药作用机制的思考:第1部分——“碳自由基”和“血红素”假说
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.
5
QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.使用HQSAR、CoMFA和CoMSIA对硫内酯衍生物进行定量构效关系分析。
SAR QSAR Environ Res. 2015;26(10):873-92. doi: 10.1080/1062936X.2015.1095238. Epub 2015 Nov 2.
6
Quantitative structure-activity relationships of the antimalarial agent artemisinin and some of its derivatives - a DFT approach.抗疟药物青蒿素及其一些衍生物的定量构效关系——一种密度泛函理论方法。
Comb Chem High Throughput Screen. 2013 Sep;16(8):590-602. doi: 10.2174/1386207311316080002.
7
3D-QSAR study on ether and ester analogs of artemisinin with comparative molecular field analysis.青蒿素醚类和酯类类似物的3D-QSAR研究及比较分子场分析
Zhongguo Yao Li Xue Bao. 1994 Nov;15(6):481-7.
8
Comparison of 3D quantitative structure-activity relationship methods: analysis of the in vitro antimalarial activity of 154 artemisinin analogues by hypothetical active-site lattice and comparative molecular field analysis.3D定量构效关系方法的比较:通过虚拟活性位点晶格和比较分子场分析对154种青蒿素类似物的体外抗疟活性进行分析
J Comput Aided Mol Des. 1998 Mar;12(2):165-81. doi: 10.1023/a:1007967517859.
9
Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin.
J Med Chem. 1993 Dec 24;36(26):4264-75. doi: 10.1021/jm00078a017.
10
Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues.基于机制的靶向寄生虫青蒿素衍生物的设计:含新型二胺类似物的合成与抗疟活性
J Med Chem. 2002 Feb 28;45(5):1052-63. doi: 10.1021/jm0109816.

引用本文的文献

1
Unveiling structural components of dibenzofuran-based MMP-12 inhibitors: a comparative classification-dependent analysis with molecular docking-based virtual screening and molecular dynamics simulation.揭示基于二苯并呋喃的基质金属蛋白酶-12抑制剂的结构成分:基于比较分类的分析与基于分子对接的虚拟筛选和分子动力学模拟
In Silico Pharmacol. 2025 Jan 7;13(1):10. doi: 10.1007/s40203-024-00296-z. eCollection 2025.
2
In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative.新型青蒿素衍生物FM-AZ的体外和计算机模拟抗疟评估
Medicines (Basel). 2022 Jan 24;9(2):8. doi: 10.3390/medicines9020008.
3
Structure-Activity Relationships of the Antimalarial Agent Artemisinin 10. Synthesis and Antimalarial Activity of Enantiomers of -5β-Hydroxy-d-Secoartemisinin and Analogs: Implications Regarding the Mechanism of Action.
抗疟药青蒿素的构效关系 10. -5β-羟基-d-青蒿内酯对映异构体和类似物的合成及抗疟活性:对作用机制的启示。
Molecules. 2021 Jul 8;26(14):4163. doi: 10.3390/molecules26144163.
4
QSAR-Based Virtual Screening of Natural Products Database for Identification of Potent Antimalarial Hits.基于定量构效关系的天然产物数据库虚拟筛选鉴定潜在抗疟化合物
Biomolecules. 2021 Mar 19;11(3):459. doi: 10.3390/biom11030459.
5
CoMFA/CoMSIA/HQSAR and Docking Study of the Binding Mode of Selective Cyclooxygenase (COX-2) Inhibitors.选择性环氧化酶(COX-2)抑制剂结合模式的比较分子场分析/比较分子相似性指数分析/基于结构的高通量虚拟筛选及对接研究
QSAR Comb Sci. 2004 Feb;23(1):36-55. doi: 10.1002/qsar.200330844. Epub 2004 Feb 18.
6
Computational Analysis of Artimisinin Derivatives on the Antitumor Activities.青蒿素衍生物抗肿瘤活性的计算分析
Nat Prod Bioprospect. 2017 Dec;7(6):433-443. doi: 10.1007/s13659-017-0142-x. Epub 2017 Nov 1.
7
Microbial transformation of the sesquiterpene lactone tagitinin C by the fungus Aspergillus terreus.土曲霉对倍半萜内酯 tagitinin C 的微生物转化。
J Ind Microbiol Biotechnol. 2012 Nov;39(11):1719-24. doi: 10.1007/s10295-012-1165-2. Epub 2012 Jul 11.
8
Fragment-based QSAR: perspectives in drug design.基于片段的定量构效关系:药物设计中的前景
Mol Divers. 2009 Aug;13(3):277-85. doi: 10.1007/s11030-009-9112-5. Epub 2009 Jan 31.
9
Modeling of peroxide activation in artemisinin derivatives by serial docking.通过系列对接对青蒿素衍生物中过氧化物活化进行建模。
J Mol Model. 2009 Jul;15(7):847-58. doi: 10.1007/s00894-008-0433-6. Epub 2009 Jan 14.
10
Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance.鉴于青蒿素体外耐药性的新证据,重新评估青蒿素的作用机制。
Trends Mol Med. 2006 May;12(5):200-5. doi: 10.1016/j.molmed.2006.03.005. Epub 2006 Apr 17.